A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach

Quantitative Proteomic Analysis Identified Paraoxonase 1 as a Novel Serum Biomarker for Microvascular Invasion in Hepatocellular Carcinoma

(2013) Cheng Huang et al.   JOURNAL OF PROTEOME RESEARCH

High-density lipoprotein subfractions display proatherogenic properties in overweight and obese children

(2013) Jane McEneny et al.   PEDIATRIC RESEARCH

Identification of Novel Biomarkers for Sepsis Prognosis via Urinary Proteomic Analysis Using iTRAQ Labeling and 2D-LC-MS/MS

(2013) Longxiang Su et al.   PLoS One

High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A

(2012) Markus Tölle et al.   CARDIOVASCULAR RESEARCH

Heart Disease and Stroke Statistics—2013 Update

(2012) Alan S. Go et al.   CIRCULATION

Proteomics Investigations of HDL: Challenges and Promise

(2012) Tomas Vaisar   Current Vascular Pharmacology

Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease

(2012) Xavier Pillois et al.   JOURNAL OF LIPID RESEARCH

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease

(2012) Anastazia A. Kei et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Inflammation alters HDL composition and function: Implications for HDL-raising therapies

(2012) Gunther Marsche et al.   PHARMACOLOGY & THERAPEUTICS

HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach

(2012) Alain Mangé et al.   PLoS One

The HDL proteome in acute coronary syndromes shifts to an inflammatory profile

(2011) Khalid Alwaili et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Serum amyloid A in atherosclerosis

(2011) Victoria L. King et al.   CURRENT OPINION IN LIPIDOLOGY

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

(2011) Sidney C. Smith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Uremia Alters HDL Composition and Function

(2011) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

High-Density Lipoprotein and Coronary Heart Disease

(2010) Pradeep Natarajan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Complement in atherosclerosis: friend or foe?

(2010) W. S. SPEIDL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

In Vitro Interactions of Extracellular Histones with LDL Suggest a Potential Pro-Atherogenic Role

(2010) Alan D. Pemberton et al.   PLoS One

Effects of omega-3 and -6 polyunsaturated fatty acids on ovine follicular cell steroidogenesis, embryo development and molecular markers of fatty acid metabolism

(2010) Jaime Hughes et al.   REPRODUCTION

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

(2009) Roland Klingenberg et al.   EUROPEAN HEART JOURNAL

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein

(2009) Junji Watanabe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Utility of Omega-3 Fatty Acids in Cardiovascular Disease

(2008) Adonis Saremi et al.   AMERICAN JOURNAL OF THERAPEUTICS

Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase

(2008) Rujuan Liu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Investigating sample pooling strategies for DIGE experiments to address biological variability

(2008) Natasha A. Karp et al.   PROTEOMICS